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Abstract Deletion of the yeast frataxin homologue, YFH1,
elicits accumulation of iron in mitochondria and mitochondrial
defects. We report here that in the presence of an iron chelator in
the culture medium, the concentration of iron in mitochondria is
the same in wild-type and YFH1 deletant strains. Under these
conditions, the activity of the respiratory complexes is restored.
However, the activity of the mitochondrial aconitase, a 4Fe-4S
cluster-containing protein, remains low. The frataxin family
bears homology to a bacterial protein family which confers
resistance to tellurium, a metal closely related to sulfur. Yfh1p
might control the synthesis of iron-sulfur clusters in mitochon-
dria.
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1. Introduction
Iron is an essential metal in mitochondria, it is present in
the heme of cytochromes and in iron-sulfur cluster-containing
proteins. However, it is a highly reactive chemical which gen-
erates toxic free radicals via the Fenton reaction and its con-
centration must be tightly controlled. Several mitochondrial
proteins, including Atm1p, an ATP-binding cassette trans-
porter located in the inner membrane [1], Ssq1p [2], a
Hsp70p-like chaperone, Oct1p, a metalloprotease involved in
the maturation of mitochondrial precursors [3], and Yfh1p [4^
7], the yeast frataxin homologue, have been shown to control
iron homeostasis. Deletion of the yeast frataxin homologue
gene (YFH1) (vYFH1) elicits a 10^15-fold increase in mito-
chondrial iron accumulation [4,5]. Iron makes deposits within
the mitochondrial matrix [2] and cannot be extruded from
mitochondria [8]. Moreover, loss of the YFH1 gene is associ-
ated with permanent activation of the high-a⁄nity iron trans-
port system in the plasma membrane [4], a process which
might contribute further to mitochondrial iron accumulation.
Iron accumulation is associated with mitochondrial dysfunc-
tion, the severity of which is strain dependent [4^6]. In some
strains, only mitochondrial respiration is decreased while in
others, respiratory de¢ciency is associated with instability or
total loss of mitochondrial DNA. De¢ciency in aconitase has
also been reported [9].
Elucidation of the function of Yfh1p will have a great med-
ical impact. Mutations in the frataxin gene are responsible for
Friedreich’s ataxia, a recessive neurodegenerative disease
often associated with cardiomyopathy with an estimated in-
cidence of 1 in 30 000 Caucasians ([10]). The localization of
human frataxin to mitochondria [11] and the presence of iron
deposits in myocardial tissues of Friedreich’s patients [12]
suggest that yeast and human frataxins may have a similar
function.
In the current paper, we have re-investigated the activity of
the respiratory complexes and aconitase under culture condi-
tions which allow us to obtain the same low iron concentra-
tion in wild-type and vYFH1 mitochondria.
2. Material and methods
2.1. Strains and media
The Saccharomyces cerevisiae strains were W303-1B (MATK ade2-1
leu2-3, 112, his3 ura3-1 trp1-1) and its isogenic deletant derivative,
W303-1BvYFH1 (vYFH1), in which the YFH1 gene has been re-
placed by a kanamycin resistance cassette [5]. Cells were grown in
ra⁄nose synthetic medium (2% ra⁄nose, 0.67% yeast nitrogen base
(Difco), 0.5% ammonium sulfate, a mixture of amino acids and the
required auxotrophic supplements). FeSO4 was solubilized in 0.1 N
HCl and immediately added to the culture medium at the indicated
concentration.
2.2. Preparation of mitochondria and measurement of respiratory
activities
Mitochondria were prepared after spheroplast lysis as previously
described [5]. Oligomycin sensitive ATPase, antimycin A sensitive
NADH cytochrome c reductase and cytochrome c oxidase were meas-
ured as previously described [5]. Aconitase activity was measured by a
standard procedure using isocitrate as the substrate [13]. Succinate
dehydrogenase activity was determined by measuring oxygen con-
sumption with a Clark-type electrode and using succinate and phena-
zine methosulfate in the presence of antimycin A.
2.3. Measurement of iron concentration
Non-heme, non-Fe-S mitochondrial iron was measured using bath-
ophenanthroline sulfonate (BPS) in the presence of dithionite as de-
scribed [14].
3. Results
3.1. Identical low iron concentrations can be obtained in
wild-type and vYFH1 mitochondria
When yeast cells were cultivated in a glucose rich medium
which had a high iron content, a 10^15-fold increase in the
mitochondrial iron concentration was observed in a vYFH1
mutant as compared to a wild-type strain [4,5]. In parallel,
cellular respiratory activity was less than 10% of the wild-type
[5]. However, under these conditions, the decreased cellular
respiration results from the combination of respiration repres-
sion by glucose and iron toxicity. By comparison, ra⁄nose
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synthetic medium o¡ers an excellent respiratory carbon source
and a lower iron concentration (approximately 1 WM). When
vYFH1 cells were shifted from glucose rich to ra⁄nose syn-
thetic medium, the iron concentration in vYFH1 mitochon-
dria progressively decreased to reach approximately twice that
of the wild-type strain after 9 h of culture (data not shown).
When 10 WM ferrous iron was added to the culture me-
dium, the mitochondrial iron content was more than 10 times
higher in the vYFH1 mutant than in the wild-type strain
(Table 1). However, when most of the iron present in the
culture medium was trapped by an iron chelator such as
BPS, the concentration of iron in mitochondria was not sig-
ni¢cantly di¡erent in the wild-type and vYFH1 strains. Iron
accumulation in mitochondria can thus be prevented by limit-
ing the iron availability in the culture medium. It can thus be
expected that under these conditions, iron does not produce
oxidative damage to vYFH1 mitochondria.
3.2. Restoration of mitochondrial respiratory activities in the
vYFH1 mutant
The activity of the respiratory complexes was measured in
cells grown in ra⁄nose synthetic medium with various iron
concentrations. When the iron concentration was higher in
vYFH1 than in wild-type mitochondria, the activity of cyto-
chrome oxidase and, to a lesser extent, that of oligomycin
sensitive ATPase and succinate dehydrogenase were signi¢-
cantly decreased (Tables 2 and 3). The activity of antimycin
A sensitive NADH cytochrome c reductase, which measures
the electron £ux through complex III, was not signi¢cantly
decreased (Table 2). When the concentration of iron was iden-
tical in vYFH1 and wild-type mitochondria (Tables 2 and 3,
+10 WM BPS), the activity of the respiratory complexes was
fully (or almost fully) restored. These data show that the
deletion of the YFH1 gene does not impair the respiratory
function per se. A decrease in the respiratory activities corre-
lates with an increased mitochondrial iron content and is
probably the result of oxidative damage.
3.3. Low aconitase activity in a vYFH1 mutant
Ro«tig et al. [9] had previously reported that aconitase ac-
tivity was very low in heart biopsies of Friedreich patients.
Similar results were obtained using extracts from yeast cells
grown in glucose rich medium [9]. As aconitase contains a
4Fe-4S cluster which is extremely labile [15], a low aconitase
activity was interpreted as the result of oxidative degradation
of the Fe-S cluster by the free radicals generated by iron [9].
We veri¢ed that when high iron concentrations were present
in vYFH1 mitochondria, aconitase activity was low (Table 3).
However, even when, after growth in the presence of BPS, no
iron accumulation occurred in vYFH1 mitochondria, aconi-
tase activity was still less than 50% of that of the wild-type
strain (Table 3). This low activity, which cannot easily be
explained by iron toxicity, might result from a defect in
iron-sulfur cluster biogenesis.
3.4. Homology between frataxin homologs and a tellurium
resistance protein family
Frataxin homologs have previously been shown to form a
unique protein family which has been largely conserved from
Gram-negative bacteria (Cyay) to humans [16], including
yeasts and plants. Using the Cyay open reading frame
(ORF) from Escherichia coli as the query, a search for se-
quence homology was carried out in the database of un¢n-
ished microbial genomes provided by the Institute for Ge-
nomic Research (Fig. 1). The E. coli Cyay ORF was not
only aligned with the Cyay ORFs from other organisms but
also with a Clostridium acetobutylicum ORF, which actually
belongs to a protein family associated with tellurite resistance
(Ter) (Fig. 1). The Ter family has members in C. acetobutyli-
cum, Bacillus subtilis, E. coli, Deinococcus radiodurans, Dic-
tyostelium and Synechocystis [17]. The Ter genes which encode
proteins of unknown function and related sequences are or-
ganized in operons borne by plasmids or by the chromosome.
Interestingly, when a reciprocal sequence homology search
[18] was run against the C. acetobutylicum ORF, in addition
to Ter ORFs, many Cyay and frataxin homologues were
found, suggesting a phylogenetic relationship between Cyay/
frataxin and Ter families (Fig. 1). Amino acid sequence ho-
mology is restricted to the N-terminal part of Ter ORFs and
corresponds to the conserved core region of the Cyay/frataxin
family. In both families, the conserved region is characterized
by the presence of numerous glycine residues, suggesting a
£exible domain, and by an invariant tryptophan residue.
The latter is followed by an hydrophobic residue in the fra-
Table 1
Iron concentration in mitochondria of wild-type and vYFH1 strains
Culture medium Iron in mitochondria (nmol/mg protein)
Wild-type vYFH1
Ra⁄nosea 4.5 þ 0.5 9.7 þ 2.0
Ra⁄nose+10 WM ironb 10.6 133
Ra⁄nose+10 WM BPSc 5.0 3.3
Ra⁄nose+5 WM BPSd 4.7 8.0
aIron concentration resulting from several independent cultures on
standard ra⁄nose medium.
bAddition of 10 WM iron to the standard medium.
cAddition of 10 WM BPS to the standard medium.
dAddition of 5 WM BPS to the standard medium.
Table 2
Activity of the respiratory complexes in wild-type and vYFH1 mitochondria
Culture mediuma Cytochrome oxidase
(U/min/mg protein)
NADH cytochrome c reductase
(Wmol/min/mg protein)
Oligomycin sensitive ATPase
(Wmol/min/mg protein)
Wild-type vYFH1 Wild-type vYFH1 Wild-type vYFH1
Ra⁄noseb 42 17 2.7 3.3 6.0 5.5
+10 WM ironb 46 9 2.2 2.4 5.5 3.0
Ra⁄nosec 59 12 2.5 2.0 4.5 3.5
+10 WM BPSc 50 34 3.5 3.2 4.6 5.5
aThe media and cultures are as in Table 1.
bThe data have been obtained from cultures carried out simultaneously.
cThe data have been obtained from cultures carried out simultaneously and independently of cultures b.
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taxin/Cyay family and by an aspartate in the Ter family (Fig.
1). Tellurite resistance is not yet understood, however, tellu-
rium and sulfur are closely related elements in the periodic
table and it has been proposed that tellurite toxicity could
result from the substitution of tellurium for sulfur in various
biochemical reactions [19].
4. Discussion
We and others had previously reported that iron accumu-
lates in mitochondria of vYFH1 mutants. This iron accumu-
lation has been associated with various mitochondrial defects.
A recent publication strongly suggests that in vYFH1 mu-
tants, iron cannot be extruded from mitochondria [8]. How-
ever, in the current report, we have shown that iron accumu-
lation in vYH1 mitochondria is not an ineluctable event.
When a vYFH1 mutant is cultivated in the presence of an
iron chelating agent that limits iron availability for the cell,
the iron concentration in mitochondria is the same in wild-
type and deletant strains. Under these conditions, activities of
the respiratory complexes and oligomycin sensitive ATPase
are restored. This means that the YFH1 deletion per se is
not deleterious to the mitochondrial function and suggests
that the decreased respiratory activities are linked to oxidative
damage caused by excess iron. However, even when in a
vYFH1 mutant, the iron concentration in mitochondria was
low, aconitase activity was still less than 50% of that in the
wild-type strain. Aconitase is a 4Fe-4S cluster-containing en-
zyme whose iron-sulfur center is extremely labile [15]. More-
over, in vertebrate cells, incorporation of the iron-sulfur clus-
ter into aconitase is reversible and this dissociation property
plays a central role in iron homeostasis regulation [20]. As
previously reported [9], our current data suggest that an ex-
cess iron elicits oxidative degradation of the iron-sulfur cluster
of the aconitase. However, they also suggest that incorpora-
tion of the iron-sulfur cluster into aconitase might be impaired
in a manner which is not linked to iron toxicity. Iron-sulfur
cluster biogenesis in yeast mitochondria is still poorly under-
stood, but there is growing evidence that homologues of the
bacterial Nif operon play a central role in this process. Nfs1p
[21] is the yeast homologue of the bacterial Nifs protein, a
cysteine desulfurase using pyridoxal phosphate as a cofactor
[22^25], which is involved in the delivery of sulfur to iron-
sulfur clusters. Nfs1p is essential to yeast life, is conserved in
humans [26] and has been shown to localize to the mitochon-
Table 3
Aconitase and succinate dehydrogenase activities in wild-type and
vYFH1 mitochondria
Culture
mediuma
Succinate dehydrogenase
(nmol O2/min/mg protein)
Aconitase (nmol/min/
mg protein)
Wild-type vYFH1 Wild-type vYFH1
Ra⁄noseb 110 65 283 66
+10 WM ironb 100 60 341 47
Ra⁄nosec 130 65 394 83
+10 WM BPSc 130 110 400 195
Ra⁄nosed 240 156 574 44
+5 WM BPSd 229 257 507 184
aThe media and cultures are as in Table 1.
bThe data have been obtained from cultures carried out simultane-
ously.
cThe data have been obtained from cultures carried out simultane-
ously and independently of cultures b and d.
dThe data have been obtained from cultures carried out simultane-
ously and independently of cultures b and c.
Fig. 1. Amino acid sequence homology between frataxin/Cyay and Ter protein families. Homologues of E. coli Cyay were searched for using
the tBLASTn program on the NCBI server, in the database of un¢nished microbial genomes (http://www.ncbi.nlm.nih.gov/BLAST/un¢nished-
genome.html). The sequence of C. acetobutylicum (AE001437) was used to run the Psi-BLAST program [18] with six iterations against the nr da-
tabases. Then, multiple amino acid alignment was performed using the Megalign program of DNASTAR and visual inspection of the sequen-
ces. Sequences A^F belong to the Ter family: A: C. acetobutylicum (AE001437); B: B. subtilis, YceD (dbjMBAA22251M) ; C: plasmid R478,
TerE (giM141975M) ; D: D. radiodurans ; E: plasmid pMJ606, TerD (spMP18781M) ; F: Dictyostelium discoideum, CABP1 (pirMMB49752); 1: E. coli,
Cyay (spMP27838M) ; 2: Actinobacillus actinomycetemcomitans, Cyay; 3: Haemophilus in£uenzae, Cyay (giM1573739); 4: Yersinia pestis, Cyay
(spMP46356M) ; 5: Vibrio cholerae, Cyay; 6: Neisseria gonorrhoeae, Cyay; 7: Thiobacillus ferrooxidans, Cyay; 8: Bordetella pertussis, Cyay; 9:
Rickettsia prowazekii, Cyay (RP323); 10: S. cerevisiae, Yfh1 (YDL120w); 11: Schizosaccharomyces pombe, frataxin homologue (giM3650374);
12: Candida albicans, frataxin homologue; 13: Mus musculus, frataxin (giM2344992); 14: Homo sapiens, frataxin (giM1237439); 15: Arabidopsis
thaliana, frataxin homologue (gbMAAD14452M). The asterisk denotes un¢nished microbial genomes. Red and blue letters indicate identical and
conservative (I/V/L, T/S, F/Y, F/W, E/D/Q/N) residues, respectively, between the Ter and frataxin/Cyay families.
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drial matrix [27]. Like YFH1 mutants, nfs1 mutants accumu-
late iron in their mitochondria [28] and exhibit aconitase de-
¢ciency [21], even though succinate dehydrogenase, a respira-
tory complex which contains an iron-sulfur subunit, Sdh2p, is
only moderately a¡ected [21]. It has been proposed that in the
nfs1 mutants, iron-sulfur metabolism is su⁄cient to maintain
succinate dehydrogenase in an active form while the more
labile aconitase is de¢cient [21]. Thus, impaired incorporation
of iron into iron-sulfur clusters could provide an explanation
to iron accumulation and deposits in the mitochondrial matrix
of vYFH1 strains.
In addition, we have found that the conserved core region
of frataxin/Cyay proteins shares sequence similarity with the
N-terminal region of small proteins conferring resistance to
tellurium (Ter). Although the function of the Ter proteins is
unknown, it is generally accepted that resistance to tellurite
results from conversion to a less toxic form. However, tellurite
is rare in the environment and it is very unlikely that the
primary function of Ter proteins is linked to tellurite detox-
i¢cation. Their large occurrence among bacteria suggests that
they play an important and basic role in cellular life. Interest-
ingly, tellurium is closely related to sulfur in the periodic table
and has been proposed to interfere with sulfur metabolism
[19]. Therefore, these data also support the hypothesis that
Yfh1p might be involved, directly or indirectly, in the regu-
lation of iron-sulfur cluster synthesis.
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